title: Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.
abstract: Hyaluronan (HA), a large glycosaminoglycan abundant in the extracellular matrix, is important in cell migration during embryonic development, cellular proliferation, and differentiation and has a structural role in connective tissues. The turnover of HA requires endoglycosidic breakdown by lysosomal hyaluronidase, and a congenital deficiency of hyaluronidase has been thought to be incompatible with life. However, a patient with a deficiency of serum hyaluronidase, now designated as mucopolysaccharidosis IX, was recently described. This patient had a surprisingly mild clinical phenotype, including notable periarticular soft tissue masses, mild short stature, an absence of neurological or visceral involvement, and histological and ultrastructural evidence of a lysosomal storage disease. To determine the molecular basis of mucopolysaccharidosis IX, we analyzed two candidate genes tandemly distributed on human chromosome 3p21.3 and encoding proteins with homology to a sperm protein with hyaluronidase activity. These genes, HYAL1 and HYAL2, encode two distinct lysosomal hyaluronidases with different substrate specificities. We identified two mutations in the HYAL1 alleles of the patient, a 1412G --> A mutation that introduces a nonconservative amino acid substitution (Glu268Lys) in a putative active site residue and a complex intragenic rearrangement, 1361del37ins14, that results in a premature termination codon. We further show that these two hyaluronidase genes, as well as a third recently discovered adjacent hyaluronidase gene, HYAL3, have markedly different tissue expression patterns, consistent with differing roles in HA metabolism. These data provide an explanation for the unexpectedly mild phenotype in mucopolysaccharidosis IX and predict the existence of other hyaluronidase deficiency disorders.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, MB R3E OW3, Canada. traine@ms.umanitoba.ca
authors.forename: B
authors.initials: B
authors.lastname: Triggs-Raine
authors.forename: T J
authors.initials: TJ
authors.lastname: Salo
authors.forename: H
authors.initials: H
authors.lastname: Zhang
authors.forename: B A
authors.initials: BA
authors.lastname: Wicklow
authors.forename: M R
authors.initials: MR
authors.lastname: Natowicz
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002874:Chromosome Mapping; D002893:Chromosomes, Human, Pair 3; D004251:DNA Transposable Elements; D005260:Female; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000737:chemistry / Q000172:deficiency / Q000235:genetics*; D007962:Leukocytes / Q000201:enzymology; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D008969:Molecular Sequence Data; D009083:Mucopolysaccharidoses / Q000097:blood / Q000201:enzymology / Q000235:genetics*; D005810:Multigene Family; D010375:Pedigree; D017354:Point Mutation; D018807:Polymorphism, Single-Stranded Conformational; D016415:Sequence Alignment; D017384:Sequence Deletion; D012689:Sequence Homology, Nucleic Acid; D013094:Spermatozoa / Q000201:enzymology
chemical_list: D004251:DNA Transposable Elements; D006821:Hyaluronoglucosaminidase